From random to precise: updated colon cancer screening and surveillance for inflammatory bowel disease
Open Access
- 1 April 2024
- journal article
- review article
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 9, 27
Abstract
Patients with inflammatory bowel disease (IBD) are at increased risk of developing colorectal cancer (CRC). The pathogenesis of CRC in IBD differs from sporadic cancer, with the burden of inflammation being an important contributing factor. Other risk factors for developing CRC in patients with Crohn’s disease (CD) or ulcerative colitis (UC) includes a family history of CRC, personal history of dysplasia, history of strictures, or primary sclerosing cholangitis (PSC). Dysplasia is the precursor of cancer and ensuring effective surveillance strategies is vital for early detection and intervention. In the past, dysplasia detection relied on random biopsies, but recent studies have shown that, with the adaptation of high-definition white light endoscopy (HD-WLE), dye sprayed chromoendoscopy (DCE) and virtual chromoendoscopy (VCE), dysplasia detection has improved. While there exists a certain degree of consensus amongst experts regarding the management of dysplasia, it is important to implement a personalized approach to each patient’s care. Our review focuses on advancements in the past two decades, specifically highlighting the modifications that have been implemented since the SCENIC guidelines. It also explores future directions, including the potential implementation of stool studies as a non-invasive tool for surveillance and the emerging role of artificial intelligence (AI) in dysplasia detection.Keywords
This publication has 87 references indexed in Scilit:
- Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia-associated lesions or masses in inflammatory bowel disease: an Internet-based studyGastrointestinal Endoscopy, 2007
- Chromoscopy-Guided Endomicroscopy Increases the Diagnostic Yield of Intraepithelial Neoplasia in Ulcerative ColitisGastroenterology, 2007
- 5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel diseaseWorld Journal of Gastroenterology, 2005
- Chromoendoscopy: An Evolving Standard in Surveillance for Ulcerative ColitisInflammatory Bowel Diseases, 2004
- The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colonGastrointestinal Endoscopy, 2003
- Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitisGastroenterology, 2003
- Family history as a risk factor for colorectal cancer in inflammatory bowel diseaseGastroenterology, 2001
- The risk of colorectal cancer in ulcerative colitis: a meta-analysisGut, 2001
- Role of bile acids in colorectal carcinogenesisEuropean Journal of Cancer, 1995
- Development of Colon Cancer After Liver Transplantation for Primary Sclerosing Cholangitis Associated With Ulcerative ColitisHepatology, 1990